KLEANGAS ENERGY TECHNOLOGIES INC Inactive Instrument
Kleangas Energy Technologies Inc Share Price Other OTC
Equities
US9737442049
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2018 | CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel | CI |
| 2018 | Joe Pavlik Joins the Advisory Board of CaliPharms, Inc | CI |
| Sales 2012 | - | Sales 2013 | - | Capitalization | 8.23M 686M |
|---|---|---|---|---|---|
| Net income 2012 | - 0 | Net income 2013 | - 0 | EV / Sales 2012 * | - |
| Net Debt 2012 | 617K 51.44M | Net Debt 2013 | 667K 55.61M | EV / Sales 2013 | - |
| P/E ratio 2012 * |
-
| P/E ratio 2013 |
-0.51
x | Employees | - |
| Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +34.37% | 5.88B | |
| -27.13% | 3.87B | |
| +4.75% | 3.28B | |
| -20.80% | 2.78B | |
| -10.70% | 2.29B | |
| +49.04% | 1.98B | |
| +49.16% | 1.54B | |
| -16.86% | 1.51B | |
| -9.87% | 1.48B |
